You just read:

Enesi Pharma Awarded Grant Funding to Develop and Evaluate ImplaVax®-enabled Solid Dose Vaccines Targeting Measles and Rubella

News provided by

Enesi Pharma

Oct 29, 2019, 03:00 ET